Mild HBOT vs Clinical HBOT: Is 2.0 ATA Better Than 1.4 ATA?
A chamber labelled 1.4 atmospheres absolute (ATA) and one rated to 2.0 ATA might look similar in a product photo, but they do not create the same pressure environment, use the same oxygen delivery method, or carry the same evidence base. Understanding mild hbot vs clinical hbot means comparing pressure, oxygen concentration, chamber construction, and the research behind each, rather than treating the ATA number as the only variable that matters.
This guide breaks down what actually changes between mild hyperbaric oxygen at 1.4 ATA and clinical HBOT at 2.0 ATA and above. It covers the underlying physiology, what human studies have found at each pressure, safety and UK regulatory context, and how to match a chamber category to your goals as a home buyer, athlete, or clinic operator.
Medical Disclaimer: This article is for general informational purposes only and does not constitute medical advice. Red light therapy devices sold by Hyperbaric Oxygen Treatment UK are wellness equipment and are not MHRA-regulated medical devices for the treatment of disease. Always consult a qualified GP or healthcare professional before using red light therapy equipment, particularly if you have any pre-existing medical conditions, are pregnant, or are currently undergoing medical treatment.
Table of Contents
1. What Is Mild HBOT vs Clinical HBOT?
Mild HBOT is a low-pressure hyperbaric session, generally below 1.5 ATA, delivered in a soft-shell chamber using concentrator-fed oxygen, while clinical HBOT is a medically supervised hyperbaric session at 2.0 ATA or higher, delivered in a hard-shell chamber using near-100% prescribed oxygen.
The Undersea and Hyperbaric Medical Society (UHMS) sets the formal minimum for clinical HBOT at 2.0 ATA, with established, scientifically supported treatments typically operating between 1.9 and 3.0 ATA under physician-directed protocols. Everything below that threshold, including the 1.4 ATA chambers commonly sold for home wellness use, falls outside the UHMS clinical definition.
Hyperbaric Oxygen Therapy (HBOT) involves entering a chamber pressurised above normal sea-level pressure while breathing air or oxygen-enriched gas. Atmospheres absolute (ATA) is the unit used to measure total chamber pressure, where 1.0 ATA is normal sea-level pressure and 2.0 ATA is double that absolute pressure. Learn more in our What Is Hyperbaric Oxygen Therapy → pillar guide.
What is mild hyperbaric oxygen at 1.4 ATA?
Mild hyperbaric oxygen 1.4 ATA describes a lower-pressure hyperbaric exposure, generally below 1.5 ATA, typically delivered in a flexible soft-shell chamber. Sessions often use an oxygen concentrator feeding 25 to 40% oxygen through a mask rather than 100% medical oxygen, and the terminology describes a pressure and equipment category rather than a proven clinical outcome. The Undersea and Hyperbaric Medical Society (UHMS) states that its formal clinical definition of HBOT requires a minimum of 2.0 ATA in a hard-sided chamber, using near-100% oxygen under a physician-directed protocol [1].
What is clinical HBOT at 2.0 ATA or above?
Clinical HBOT is a medically supervised intervention delivered in a hard-sided chamber using prescribed oxygen and a defined protocol, generally at 2.0 ATA or higher. UHMS guidance describes established, scientifically supported treatments as typically operating between 1.9 and 3.0 ATA [1]. A chamber rated to 2.0 ATA is not automatically a "clinical service" in the medical sense; that additionally depends on breathing gas purity, trained personnel, facility procedures, and the treatment protocol being followed.
Key Point - ATA measures pressure, not oxygen concentration. Always compare pressure, breathing gas, delivery method, session length, chamber construction, and supervision together, not pressure alone.
2. How Does Pressure Change Oxygen Delivery?
Direct answer: Higher pressure increases the amount of oxygen that dissolves directly into blood plasma, beyond what haemoglobin alone can carry, but pressure is only one part of the total oxygen dose delivered in a session.
Under normal atmospheric pressure, haemoglobin in healthy people is already close to fully saturated with oxygen. Raising chamber pressure increases what NHS England describes as the proportion of oxygen dissolved directly in blood plasma, which is separate from haemoglobin saturation, and this proportion rises with both higher pressure and higher inspired oxygen concentration [2].
A 60-minute session at 1.4 ATA using a concentrator-fed mask therefore delivers a meaningfully different oxygen dose than a 60-minute session at 1.4 ATA breathing 100% medical oxygen, and neither is directly comparable to a 2.0 ATA clinical protocol.
Does 2.0 ATA deliver twice the effect of 1.0 ATA?
No. Pressure and biological outcome do not have a simple one-to-one relationship. A 2023 study published in the International Journal of Molecular Sciences directly compared one 60-minute session of 100% oxygen at 1.4 ATA against one 60-minute session at 2.5 ATA in 14 healthy non-smoking volunteers. Both pressures produced a similar rise and pattern of plasma reactive oxygen species over 48 hours, with no statistically significant difference between the two pressure groups for that marker.
However, some immune-response markers, including urinary neopterin, rose significantly more after the 2.5 ATA exposure than after the 1.4 ATA exposure, indicating that immunomodulatory and inflammatory responses scaled with oxygen dose even though oxidative stress kinetics did not. The study used only six participants at 1.4 ATA and eight at 2.5 ATA, measured biomarkers rather than clinical outcomes, and did not test repeated wellness protocols [3].
3. Mild HBOT vs Clinical HBOT: Side-by-Side
The practical differences between soft shell mild HBOT and clinical HBOT pressure setups extend well beyond the ATA number on the display. This table separates equipment and use context without mapping any medical condition to a chamber.
Factor | Mild HBOT at 1.4 ATA | Clinical HBOT at 2.0+ ATA |
Typical chamber | Flexible soft shell | Rigid hard shell, sometimes multiplace |
Pressure | 1.2 to 1.5 ATA | 2.0 to 2.5 ATA in the ranges sold by Hyperbaric Oxygen Treatment UK |
Common context | Home wellness, athlete training environments, smaller wellness facilities | Professionally managed clinics, sports performance facilities, high-throughput environments |
Oxygen delivery | Often a concentrator-fed mask, 25–40% oxygen | Defined oxygen delivery under a supervised protocol, up to near-100% |
Installation | Lighter, less structurally demanding | Heavier equipment, floor-loading and access planning, more extensive commissioning |
Portability | Often movable or deflatable | Movable for soft shell version, but normally a permanent installation for hard shell unit |
Evidence base | Human physiology studies exist; clinical outcome evidence is more limited | Larger established literature for UHMS-recognised, medically supervised uses |
Entry price (Hyperbaric Oxygen Treatment UK range) | From £8,499 | From £12,000 for a soft shell unit and £29,999 for a hard shell monoplace unit |
Hyperbaric Oxygen Treatment UK also supplies a 2 ATA soft shell hyperbaric chamber →, one of the few soft-shell chambers on the UK market rated to a full clinical HBOT pressure of 2 ATA. It combines the higher pressure typically associated with hard-shell equipment with the lighter weight, easier access, and lower footprint of a soft-shell build, making it one of the best value-for-money options for home buyers who want 2 ATA performance without the cost, floor-loading, and installation demands of a rigid hard-shell chamber.
Can a low-pressure chamber reproduce a 2.0 ATA protocol by running longer?
No, not by extending session length alone. Duration, pressure, and oxygen concentration are separate dose variables that do not substitute for one another. A longer low-pressure session should not be marketed as equivalent to a shorter clinical protocol without direct comparative research, and clinical results generated at 2.0 or 2.5 ATA should not be used to promote low pressure HBOT performance claims. Learn more about how each pressure tier is classified in our HBOT pressure levels explained → guide.
4. The Evidence: What Research Shows
Human research confirms that both mild and clinical pressures produce measurable physiological responses, but the evidence does not establish that the two pressure ranges deliver equal clinical outcomes, and the strongest direct comparison studies remain small and short.
A 2023 randomised crossover study published in the journal Life exposed 16 healthy women aged 20 to 28 to one 70-minute session at 1.4 ATA with 35–39.5% oxygen, compared against a normobaric control session. The researchers reported a significant acute increase in parasympathetic nervous system activity and a significant rise in peripheral natural killer (NK) cell count after the mild HBOT exposure, while inflammatory cytokines (IL-6, IL-12p70) and oxidative stress markers (d-ROMs) did not change significantly. The authors noted this reflected an acute, single-session effect in a small, female-only cohort, with no long-term or clinical endpoint measured [4].
A related 2023 single-blind study published in Frontiers in Neurology exposed 10 healthy adults to plain room air at just 1.27 ATA (below the typical 1.4 ATA mild HBOT threshold) for 90 minutes, 10 times over two weeks. A population of circulating stem progenitor cells increased almost two-fold by the ninth exposure and nearly three-fold 72 hours after the final session, a statistically significant and durable change. The authors highlighted this as evidence that even very low hyperbaric pressures are not physiologically inert, which has implications for how "sham" or placebo chambers are designed in hyperbaric research, though the study did not establish any clinical benefit and involved a small sample of 10 people [5].
This placebo-design question is not new. A 2018 narrative review in Clinical Trials examined 42 randomised hyperbaric trials and found that 23 had used a lower-pressure "sham" condition breathing 21% oxygen, with sham pressures ranging from 1.1 to 1.5 ATA. The authors concluded that sham design in hyperbaric research needs careful reconsideration, because even modest pressure increases can measurably affect gas partial pressures in tissue and may not be a fully inert comparator [6].
At the higher end of the pressure range, the Undersea and Hyperbaric Medical Society recognises established clinical indications for HBOT, including decompression sickness, arterial gas embolism, carbon monoxide poisoning, chronic refractory osteomyelitis, radiation tissue injury, and certain non-healing wounds, all treated in medically supervised clinical environments at a minimum of 2.0 ATA [1]. Beyond that recognised list, researchers are investigating HBOT's potential role in a number of additional areas at various pressures. These remain investigational applications, the evidence continues to develop, and larger trials are needed; this is not a recommendation to use HBOT for any investigational purpose.
Expert Note - In 2025, the Italian Society of Hyperbaric and Underwater Medicine (SIMSI) published a position statement noting that low-pressure chambers operating below 1.5 ATA use non-medical-grade oxygen concentrators and lack the continuous oxygen monitoring found in multiplace clinical chambers, and stated that current scientific literature provides little evidence supporting HBOT below 2.0 ATA for UHMS-recognised clinical indications [7]. The UHMS and several national hyperbaric societies have taken similar positions on low-pressure, soft-sided chambers. This underlines why mild-pressure equipment should be marketed and used as wellness equipment, not as a substitute for supervised clinical HBOT.
5. Who Uses Each Pressure Range?
Home wellness users commonly compare 1.4 to 1.5 ATA soft-shell chambers, while established clinics and higher-throughput facilities often consider rigid 2.0 ATA systems. Buyer type is a practical guide, not a medical prescription.
Who uses mild hyperbaric oxygen at 1.4 ATA?
Typical buyers include:
Private home wellness users
Athletes incorporating HBOT into a wider training environment
Personal trainers and performance facilities
Wellness practices offering individual sessions
First-time chamber buyers prioritising space and purchase cost
Soft-shell systems normally place fewer demands on access and floor loading than large rigid chambers. Some include internal controls for independent operation after installation and training.
Who uses clinical HBOT pressure equipment?
2.0 ATA and higher-pressure systems are more commonly considered by:
Established wellness clinics
Professional sports facilities
Physiotherapy practices
Higher-volume commercial operators
Facilities with trained staff and defined operating procedures
Premium home buyers planning a permanent installation
Tom Aspinall and Savannah Marshall use chambers supplied by Hyperbaric Oxygen Treatment UK in their training and wellness environments. Their use illustrates athlete adoption and is not evidence of medical effectiveness.
Clinic operators comparing 2.0 ATA and 2.5 ATA hard-shell options should also review our HBOT pressure levels explained → guide before purchasing.
Explore Our Hyperbaric Oxygen Chamber Range
Explore our chambers by pressure, shell type, capacity, and price. Speak to Daniel and the team before buying so the model can be matched to your room, access route, user type, and operational requirements.
📱 WhatsApp: +44 7401 003989
📧 Email: info@hyperbaricoxygentreatment.uk
📞 Phone: +44 7401 003989
6. Pressure Levels and Chamber Options
Chambers are generally described as soft shell (flexible, inflatable, portable) or hard shell (rigid, fixed pressure vessel, higher maximum pressure). Soft shell mild HBOT units usually top out around 1.5 ATA, though Hyperbaric Oxygen Treatment UK also lists a soft shell model rated to 2.0 ATA, so shell type and pressure should not be assumed to be strictly linked. Compare shell construction in full in our hard shell vs soft shell hyperbaric chamber → guide.
ATA Level | Typical chamber format | Suitable For |
1.4-1.5 ATA | Soft-shell monoplace or two-person chamber | Home wellness users, athletes incorporating HBOT into training routines |
2.0 ATA Soft Shell | Higher-pressure soft-shell personal or professional chamber | Experienced home HBOT users, premium wellness, mid-tier clinic environments |
2.0 ATA Hard Shell | Hard-shell monoplace, or multiplace chamber | Professional clinic standard, sports performance facilities, high-volume clinical use |
2.5 ATA | Rigid specialist chamber | Hospital and specialist clinical environments, highest-pressure professional use |
Four Chamber Models Compared
This comparison spans two soft-shell recline models at different pressure ceilings, alongside a permanent hard-shell single-user unit and a stainless-steel multiplace system. The 1.5 ATA XXL Recline Model and 2.0 ATA Deep Dive both let you sit up or lie flat in the same soft-shell format, while the Hard Chamber Pro and Multiplace 2 ATA move into rigid construction for permanent clinic or high-throughput use.
Specification | 1.5 ATA XXL Recline Model | 2.0 ATA Deep Dive (Soft Shell) | 2.0 ATA Hard Chamber Pro | Multiplace 2 ATA |
Primary buyer | Home wellness user, athlete, or spacious-room buyer | Home or clinic buyer wanting the highest pressure in a soft shell | Clinic or permanent premium home installation | Higher-throughput clinic or facility |
Shell | Soft shell, internal metal frame | Soft shell, thermal-welded seams, external metal frame | Rigid hard shell | Stainless-steel rigid chamber |
Maximum pressure | 1.5 ATA (pressure switch: 1.2–1.5 ATA) | 2.0 ATA (14.7 psi), blast-tested to 3 ATA | 2.0 ATA | 2.0 ATA |
Capacity | One person, sit or lie flat | One person, sit or lie flat | One person | Two or four people |
Dimensions | 230 × 110 × 120 cm | 200 × 110 cm | 240 × 85 cm | 2-person: 220 × 160 × 170 cm; 4-person: 280 × 160 × 170 cm |
Listed weight | Confirm before ordering | Confirm before ordering | 450 kg | 1,800 kg or 2,000 kg |
Oxygen equipment | 10 LPM concentrator, oil-free compressor | 10 LPM concentrator, oil-free compressor | Integrated 10 LPM concentrator | 20 LPM or 40 LPM, based on capacity |
Current listed price | £9,499 | £14,000 | £29,999 | £79,999 or £88,000 |
Installation focus | Room clearance and doorway access | Room clearance and doorway access | Access route, clearance and structural floor capacity | Structural assessment and detailed logistics plan |
Best fit | Spacious home wellness, taller users, athletes | Stepping up from 1.5 ATA without moving to hard shell | Repeated individual sessions in a clinic or home setting | Shared sessions and commercial throughput |
1.5 ATA XXL Recline Model
The XXL Recline Model is our largest soft-shell chamber, measuring 230 × 110 × 120 cm with enough length to lie completely flat and enough headroom to sit fully upright. It offers a pressure switch across 1.2, 1.3, 1.4, or 1.5 ATA, a triple-zip closure operable from inside, two viewing windows, and a reclining fold-up chair. The listed package includes a 10 LPM oxygen concentrator, oil-free compressor, masks, hoses, delivery, installation, and training.
2.0 ATA Deep Dive (Soft Shell)
The Deep Dive Sit or Lie Down reaches 2.0 ATA (14.7 psi), the highest pressure available in a soft-shell format, and is blast-tested to 3 ATA for a safety margin above its operating limit. At 200 × 110 cm, the reclining sofa chair folds down into a full memory-foam mattress, and thermal-welded seams with a stainless-steel buckle system are built for the higher pressure. It suits buyers who have outgrown a 1.5 ATA chamber but do not want the installation footprint of a rigid hard shell.
2.0 ATA Hard Chamber Pro
The Hard Chamber Pro provides clinical HBOT 2 ATA pressure capability for permanent professional or premium home installations. The rigid, single-person chamber includes a sliding door, three viewing windows, internal and external controls, and a two-way intercom. It measures 240 × 85 cm and weighs 450 kg, so buyers must confirm floor capacity, delivery access, and working clearance before installation. The current listed price is £29,999.
Multiplace 2 ATA
The Multiplace 2 ATA is designed for facilities needing two or four occupants in one session. The two-person configuration weighs approximately 1,800 kg, while the four-person version weighs approximately 2,000 kg. Power-reclining seats, integrated entertainment, internal and external controls, and two-way communication support a staff-operated environment. A structural assessment and access plan are essential before purchase.
7. Real-World Installation Examples
Hyperbaric Oxygen Treatment UK has completed 120+ professional installations across the UK, Europe, and internationally, spanning both mild and clinical pressure ranges. Three recent examples illustrate the range and the logistics involved at each pressure tier.
In Birmingham, our team installed a 2.0 ATA Hard Chamber Pro, weighing around 450kg, for a private home user seeking clinic-standard specification in a residential setting. At that weight and footprint, floor loading and access route needed confirming before delivery, and Daniel and the team completed the installation and hands-on training in a single visit. Birmingham 2.0 ATA Hard Chamber Pro installation →
In Bangkok, Thailand, the team installed a 1.5 ATA two-person chamber for a home wellness buyer, a project that involved international freight, customs coordination, full pressure testing, and on-site training, illustrating the logistics involved in the softer-shell, lower-pressure end of an international installation. 2 Person XL Hyperbaric Chamber Installation in Bangkok, Thailand →
In Fife, Scotland, a new wellness clinic selected a 1.5 ATA XXL sit-or-lie model to serve clients in a mild-pressure format suited to a wellness-focused business. You can see this and other examples on our installations page.
8. Safety and UK Regulatory Context
HBOT has a well-established safety record when used correctly at appropriate pressures, but it is not suitable for everyone. Always consult your GP before use, particularly if you have any pre-existing conditions, are pregnant, or have ear, sinus, or lung conditions that affect pressure equalisation.
A 2023 systematic review and meta-analysis published in Frontiers in Medicine examined adverse effects across HBOT protocols and found that HBOT is more likely to cause adverse reactions once chamber pressure exceeds 2.0 ATA, reinforcing why higher-pressure clinical protocols typically involve closer medical oversight [8]. Lower-pressure sessions generally involve a gentler equalisation process, which is one reason soft shell mild HBOT chambers are widely used in unsupervised home settings, though "lower pressure" does not mean risk-free; equipment quality, screening, and correct use still matter.
NHS England describes clinical HBOT as breathing pure oxygen, usually at 2 to 3 ATA, for approximately 45 to 120 minutes per session, delivered in a hospital or specialist facility [2]. NHS commissioning of HBOT is indication-specific, and NHS policy documents note that for some proposed uses the evidence base is not currently considered sufficient to support routine funding, illustrating how cautiously UK clinical bodies weigh HBOT evidence even at established 2 to 3 ATA pressures [2].
Key Point - Pressure and supervision level tend to move together. Lower-pressure sessions are generally more forgiving for home use, while higher clinical pressures benefit from trained oversight, proper chamber construction, and a clear, medically-directed protocol.
9. Investment Considerations
Chamber pricing varies significantly between mild and clinical pressure tiers, reflecting differences in construction, materials, and pressure-rated components. At Hyperbaric Oxygen Treatment UK, list pricing currently starts at £8,499 for the 1.4 ATA Comfort Model, rises to £29,999 for the 2.0 ATA Hard Chamber Pro hard-shell monoplace unit, and reaches £79,999 to £88,000 for the two-person and four-person 2 ATA multiplace systems built for clinics and wellness centres.
Hyperbaric Oxygen Treatment UK holds a 4.8-star rating from over 80 verified reviews on Trustpilot, with customers frequently noting prompt delivery, professional in-person installation, and a no-pressure sales approach where buyers are left to decide at their own pace.
Business finance is available through an external finance partner, and buyers should also budget for room preparation, access routes, electrical supply, and any travel charges beyond the 20-mile free installation radius from Cleveleys. Daniel personally handles sales, installation, and ongoing WhatsApp and telephone support after purchase.
Not Sure Which Pressure Level Suits You?
Whether you are weighing up mild hyperbaric oxygen 1.4 ATA for daily wellness or a 2.0 ATA clinical-pressure chamber for a business setup, our team can talk you through the right specification for your space, budget, and goals.
📱 WhatsApp: +44 7401 003989
📧 Email: info@hyperbaricoxygentreatment.uk
📞 Phone: +44 7401 003989
10. Frequently Asked Questions
Q. Is 1.4 ATA real HBOT?
A. A 1.4 ATA chamber creates a genuine hyperbaric environment, but major clinical organisations distinguish it from clinical HBOT. Human studies report measurable physiological responses at 1.4 ATA, such as increased parasympathetic activity and natural killer cell counts, yet the UHMS clinical definition requires at least 2.0 ATA in a compliant hard-sided chamber with prescribed medical oxygen and physician oversight [4][1].
Q. What is the main difference between mild and clinical HBOT?
A. The main difference is the complete oxygen dose and delivery context, not pressure alone. Mild systems generally use lower pressure, flexible chambers, and concentrator-fed oxygen, while clinical HBOT combines higher pressure, near-100% oxygen delivery, medical screening, and formal operating standards.
Q. Does higher ATA always produce better results?
A. No, higher ATA is not automatically better for every objective. A 2023 direct comparison study found similar oxidative stress kinetics at 1.4 ATA and 2.5 ATA, though immune-response markers scaled more strongly with the higher pressure, showing that different biological responses do not all move in the same proportion as pressure [3].
Q. Which ATA level do I need for home use?
A. Most home wellness buyers consider 1.4 to 1.5 ATA soft-shell chambers, but the right level depends on space, access, budget, and professional advice. Some experienced buyers install rigid 2.0 ATA hard-shell systems at home, though these require more extensive delivery, floor-loading checks, and training.
Q. Can a 1.4 ATA chamber match a 2.0 ATA session by running longer?
A. There is no verified conversion formula that makes a longer 1.4 ATA session equivalent to a 2.0 ATA protocol. Pressure, oxygen concentration, and duration each influence the exposure independently, so the specified protocol for the equipment should always be followed.
Q. What is the difference between a soft shell and hard shell chamber?
A. A soft shell uses flexible, reinforced material and is generally easier to position or move, while a hard shell uses rigid construction and supports higher, more consistent pressure for permanent professional installations. Read the full comparison in our hard shell vs soft shell hyperbaric chamber → guide.
Q. How much does a hyperbaric oxygen chamber cost to buy?
A. Costs vary by pressure rating, shell type, and size. At Hyperbaric Oxygen Treatment UK, list pricing starts at £8,499 for a 1.4 ATA soft-shell model and reaches £88,000 for a four-person 2 ATA multiplace clinical system, with finance available for business customers.
Q. What's the best hyperbaric chamber to buy in the UK?
A. The best chamber depends on intended use: soft-shell 1.4-1.5 ATA models suit home wellness and athletes, while hard-shell 2.0-2.5 ATA models suit clinics and business buyers wanting professional-grade specification. Compare verified specifications and installation needs, and speak to Daniel and the team for a tailored shortlist.
Q. Is clinical HBOT at 2.0 ATA safe?
A. HBOT has a well-established safety record when used appropriately, but a 2023 systematic review in Frontiers in Medicine found adverse reaction rates increase once pressure exceeds 2.0 ATA. Clinical-pressure sessions typically involve closer oversight, and a GP consultation is recommended first, particularly for pre-existing conditions [8].
Q. Does the NHS recommend HBOT?
A. NHS-commissioned hyperbaric services in England describe clinical HBOT as usually running at 2 to 3 ATA for 45 to 120 minutes per session, reserved for specific, carefully evaluated indications rather than general wellness use. This is distinct from mild-pressure wellness chambers, which sit outside NHS clinical protocols entirely [2].
11. Why Choose Hyperbaric Oxygen Treatment UK
Hyperbaric Oxygen Treatment UK is a member of the International Board of Undersea Medicine (IBUM) and the International Hyperbarics Association (IHA), and has completed 120+ installations spanning mild and clinical pressure ranges across the UK, Europe, and internationally. Our range covers everything from the £8,499 1.4 ATA Comfort Model through to the £88,000 four-person 2 ATA Multiplace system, so whichever side of the mild hbot vs clinical hbot decision suits you, our team can specify, deliver, and install the right chamber.
12. Conclusion
Mild HBOT and clinical HBOT differ in pressure, chamber construction, oxygen delivery, evidence base, and typical use case, and treating them as interchangeable overlooks physiological differences confirmed in peer-reviewed research, from oxidative stress kinetics to immune-marker responses.
Soft-shell 1.4-1.5 ATA chambers suit home wellness users and athletes wanting a daily routine, while hard-shell 2.0 ATA and above chambers suit clinics and buyers wanting professional-grade specification and UHMS-aligned construction standards.
Hyperbaric Oxygen Treatment UK, with 120+ installations and a 4.8-star Trustpilot rating from over 80 reviews, supplies and installs both categories across the UK, Europe, and internationally. Contact our team to discuss which pressure level and model fits your space, budget, and goals.
Explore Our Hyperbaric Oxygen Chambers
Our range spans the 1.4 ATA Comfort Model for home wellness through to the 2.0 ATA Hard Chamber Pro and 2 ATA Multiplace system for clinical-standard, high-throughput use. Every purchase includes professional installation, hands-on training, and ongoing support from Daniel and the team.
📱 WhatsApp: +44 7401 003989
📧 Email: info@hyperbaricoxygentreatment.uk
📞 Phone: +44 7401 003989
Medical Disclaimer: This article is for general informational purposes only and does not constitute medical advice. Red light therapy devices sold by Hyperbaric Oxygen Treatment UK are wellness equipment and are not MHRA-regulated medical devices for the treatment of disease. Always consult a qualified GP or healthcare professional before using red light therapy equipment, particularly if you have any pre-existing medical conditions, are pregnant, or are currently undergoing medical treatment.
Published by the content team at Hyperbaric Oxygen Treatment UK, a professional hyperbaric oxygen chamber and red light therapy equipment supplier and installer based in Cleveleys, Lancashire, with 120+ installations across the UK, Europe, and internationally. Member of the International Board of Undersea Medicine (IBUM) and the International Hyperbarics Association (IHA).
13. References & Medical Sources
Undersea and Hyperbaric Medical Society. "Indications for Hyperbaric Oxygen Therapy." UHMS. https://www.uhms.org/resources/featured-resources/hbo-indications.html
NHS England (2018/2019). "Hyperbaric Oxygen Therapy for necrotising soft tissue infections: Clinical Commissioning Policy." https://www.england.nhs.uk/wp-content/uploads/2018/07/hbot-for-necrotising-soft-tissue-infections-v2.pdf
Leveque C, Mrakic Sposta S, Theunissen S, et al. (2023). "Oxidative Stress Response Kinetics after 60 Minutes at Different (1.4 ATA and 2.5 ATA) Hyperbaric Hyperoxia Exposures." International Journal of Molecular Sciences, PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC10418619/
Un Nisa B, Nakanishi R, Tanaka M, et al. (2023). "Mild Hyperbaric Oxygen Exposure Enhances Peripheral Circulatory Natural Killer Cells in Healthy Young Women." Life, PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC9965672/
MacLaughlin KJ, Barton GP, Braun RK, et al. (2023). "Hyperbaric Air Mobilizes Stem Cells in Humans; A New Perspective on the Hormetic Dose Curve." Frontiers in Neurology, PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC10318163/
Lansdorp NCA, van Hulst RA. (2018). "Double-Blind Trials in Hyperbaric Medicine: A Narrative Review on Past Experiences and Considerations in Designing Sham Hyperbaric Treatment." Clinical Trials, PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC6136075/
SIMSI (Italian Society of Hyperbaric and Underwater Medicine) (2025). "SIMSI Position on the use of Low-Pressure Hyperbaric Chambers for Hyperbaric Oxygen Therapy (HBO2)." UHMS Pressure publication. https://www.uhms.org/pressure-other-articles/1574-simsi-position-on-the-use-of-low-pressure-hyperbaric-chambers-for-hyperbaric-oxygen-therapy-hbot.html
Systematic review and meta-analysis (2023). "Adverse effects of hyperbaric oxygen therapy." Frontiers in Medicine. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1160774/full
This guide is brought to you by Hyperbaric Oxygen Treatment UK, a member of the International Board of Undersea Medicine (IBUM) and the International Hyperbarics Association (IHA), with 120+ professional installations across the UK, Europe, and internationally.
Comments